|B-Raf (Cell-free assay)|
|In vitro (25°C)||DMSO||5 mg/mL (11.02 mM)|
|Water||<1 mg/mL (<1 mM)|
|Ethanol||<1 mg/mL (<1 mM)|
|In vivo||2% Cremophor EL, 2% N,N-dimethylacetamide, pH 5.0||30 mg/mL|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||22.05 mL||110.25 mL||220.51 mL|
|0.5 mM||4.41 mL||22.05 mL||44.1 mL|
|1 mM||2.21 mL||11.03 mL||22.05 mL|
|5 mM||0.44 mL||2.21 mL||4.41 mL|
*The above data is based on the productmolecular weight 453.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
PLX7904 is a potent and selective paradox-breaker RAF inhibitor. It is able to efficiently inhibit activation of ERK1/2 in mutant BRAF melan…
L-779450 is a raf kinase inhibitor, a potential treatment for neurotraumatic diseases.
Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 μM.
Dabrafenib Mesylate is a novel, potent, and selective Raf kinase inhibitor that is capableof inhibiting the kinase activity of wild-type B-R…